FDA Commissioner Dr. Marty Makary tells CBS News’ Norah O’Donnell in an exclusive interview why the agency decided to drop decades-old “black box” warnings on many hormone therapy drugs used for menopause and perimenopause symptoms.
Featured Government Shutdown 2025 Trump Pardons UFC News NFL Week 10 Follow Us On YouTube Facebook Instagram X Privacy Privacy Policy California Notice Your Privacy Choices Terms of Use More from CBS News Newsletters Podcasts Download Our App Brand Studio Sitemap Company About Paramount Advertise With Paramount Join Our Talent Community Help Feedback Contact the Ombudsman
Copyright ©2025 CBS Interactive Inc. All rights reserved.
Share this:
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on X (Opens in new window) X
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on Tumblr (Opens in new window) Tumblr